Shortwave Life Sciences (AQSE:PSY) Enterprise Value : £0.00 Mil (As of Jun. 20, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shortwave Life Sciences's Enterprise Value is £0.00 Mil. Shortwave Life Sciences does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Shortwave Life Sciences's EV-to-EBIT at this moment.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Shortwave Life Sciences's Enterprise Value is £0.00 Mil. Shortwave Life Sciences does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Shortwave Life Sciences's EV-to-EBITDA at this moment.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Shortwave Life Sciences's Enterprise Value is £0.00 Mil. Shortwave Life Sciences does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Shortwave Life Sciences's EV-to-Revenue at this moment.

Shortwave Life Sciences Enterprise Value Historical Data

The historical data trend for Shortwave Life Sciences's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences Enterprise Value Chart

Shortwave Life Sciences Annual Data

Trend

Enterprise Value

Shortwave Life Sciences Semi-Annual Data

Enterprise Value

Competitive Comparison of Shortwave Life Sciences's Enterprise Value

For the Biotechnology subindustry, Shortwave Life Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shortwave Life Sciences's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shortwave Life Sciences's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Shortwave Life Sciences's Enterprise Value falls into.

Shortwave Life Sciences Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Shortwave Life Sciences's Enterprise Value for the fiscal year that ended in . 20 is calculated as

	Enterprise Value (A: . 20 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=		+		+
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Cash, Cash Equivalents, Marketable Securities
+		+		-
=	0.00

Shortwave Life Sciences's Enterprise Value for the quarter that ended in . 20 is calculated as

	Enterprise Value (Q: . 20 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=		+		+
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Cash, Cash Equivalents, Marketable Securities
+		+		-
=	0.00

Shortwave Life Sciences (AQSE:PSY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

Shortwave Life Sciences Enterprise Value Related Terms

Thank you for viewing the detailed overview of Shortwave Life Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Shortwave Life Sciences (AQSE:PSY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » Enterprise Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.psych.capital

Psych Capital PLC is an incubation and pre-seed investment firm that deploys early-stage capital while usually operating or supporting emerging companies in the UK's and Europe's psychedelic science and healthcare industry.